Blake DR[au] - Search Results

Year	Number of Results
1974	1
1978	3
1979	5
1980	5
1981	10
1982	4
1983	3
1984	8
1985	13
1986	8
1987	16
1988	10
1989	16
1990	12
1991	24
1992	30
1993	25
1994	14
1995	13
1996	17
1997	15
1998	15
1999	8
2000	5
2001	4
2002	2
2003	11
2004	12
2005	13
2006	5
2007	7
2008	12
2009	7
2010	2
2011	11
2012	14
2013	10
2014	8
2015	8
2016	10
2017	6
2018	9
2019	7
2020	6
2021	5

1

Gain-of-Function RHOA Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric Cancer.

Zhang H, Schaefer A, Wang Y, Hodge RG, Blake DR, Diehl JN, Papageorge AG, Stachler MD, Liao J, Zhou J, Wu Z, Akarca FG, de Klerk LK, Derks S, Pierobon M, Hoadley KA, Wang TC, Church G, Wong KK, Petricoin EF, Cox AD, Lowy DR, Der CJ, Bass AJ. Zhang H, et al. Among authors: blake dr. Cancer Discov. 2020 Feb;10(2):288-305. doi: 10.1158/2159-8290.CD-19-0811. Epub 2019 Nov 26. Cancer Discov. 2020. PMID: 31771969 Free PMC article.

2

KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism.

Vaseva AV, Blake DR, Gilbert TSK, Ng S, Hostetter G, Azam SH, Ozkan-Dagliyan I, Gautam P, Bryant KL, Pearce KH, Herring LE, Han H, Graves LM, Witkiewicz AK, Knudsen ES, Pecot CV, Rashid N, Houghton PJ, Wennerberg K, Cox AD, Der CJ. Vaseva AV, et al. Among authors: blake dr. Cancer Cell. 2018 Nov 12;34(5):807-822.e7. doi: 10.1016/j.ccell.2018.10.001. Cancer Cell. 2018. PMID: 30423298 Free PMC article.

3

Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.

Blake DR, Robson P, Ho M, Jubb RW, McCabe CS. Blake DR, et al. Rheumatology (Oxford). 2006 Jan;45(1):50-2. doi: 10.1093/rheumatology/kei183. Epub 2005 Nov 9. Rheumatology (Oxford). 2006. PMID: 16282192 Clinical Trial.

4

Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer.

Blake DR, Vaseva AV, Hodge RG, Kline MP, Gilbert TSK, Tyagi V, Huang D, Whiten GC, Larson JE, Wang X, Pearce KH, Herring LE, Graves LM, Frye SV, Emanuele MJ, Cox AD, Der CJ. Blake DR, et al. Sci Signal. 2019 Jul 16;12(590):eaav7259. doi: 10.1126/scisignal.aav7259. Sci Signal. 2019. PMID: 31311847 Free PMC article.

5

Human Papillomavirus Vaccine Update.

Blake DR, Middleman AB. Blake DR, et al. Pediatr Clin North Am. 2017 Apr;64(2):321-329. doi: 10.1016/j.pcl.2016.11.003. Pediatr Clin North Am. 2017. PMID: 28292448 Review.

6

Understanding pain.

Haigh RC, Blake DR. Haigh RC, et al. Among authors: blake dr. Clin Med (Lond). 2001 Jan-Feb;1(1):44-8. doi: 10.7861/clinmedicine.1-1-44. Clin Med (Lond). 2001. PMID: 11358075 Free PMC article. Review. No abstract available.

7

Nitric oxide.

Farrell AJ, Blake DR. Farrell AJ, et al. Among authors: blake dr. Ann Rheum Dis. 1996 Jan;55(1):7-20. doi: 10.1136/ard.55.1.7. Ann Rheum Dis. 1996. PMID: 8572740 Free PMC article. Review. No abstract available.

8

Phantoms in rheumatology.

McCabe CS, Haigh RC, Shenker NG, Lewis J, Blake DR. McCabe CS, et al. Among authors: blake dr. Novartis Found Symp. 2004;260:154-74; discussion 174-8, 277-9. doi: 10.1002/0470867639.ch11. Novartis Found Symp. 2004. PMID: 15283449 Review.

9

Point-of-care testing for diabetes.

Blake DR, Nathan DM. Blake DR, et al. Crit Care Nurs Q. 2004 Apr-Jun;27(2):150-61. doi: 10.1097/00002727-200404000-00007. Crit Care Nurs Q. 2004. PMID: 15137357 Review.

10

The pharmacology of ebselen.

Parnham MJ, Leyck S, Graf E, Dowling EJ, Blake DR. Parnham MJ, et al. Among authors: blake dr. Agents Actions. 1991 Jan;32(1-2):4-9. doi: 10.1007/BF01983300. Agents Actions. 1991. PMID: 2058468 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results